Meeting
2023 ASCO Annual Meeting
Oncologists’ receipt of pharmaceutical industry payments and use of non-recommended and low-value cancer care services.
Authors
Aaron Philip Mitchell
Memorial Sloan Kettering Cancer Center, New York, NY
Aaron Philip Mitchell , Stacie B Dusetzina , Akriti Mishra Meza , Niti U. Trivedi , Peter Brian Bach , Aaron N Winn
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Health Services Research and Quality Improvement
Track
Quality Care/Health Services Research
Sub Track
Value/Cost of Care
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6639)
DOI
10.1200/JCO.2023.41.16_suppl.6639
Abstract #
6639
Poster Bd #
131
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Quality Care Symposium
Cost to Medicare from bone modifying agent overuse in castration-sensitive prostate cancer.
First Author: Aaron Philip Mitchell
Poster
2023 ASCO Quality Care Symposium
Frequency of anti-resorptive therapy prescription and skeletal disease screening in patients diagnosed with multiple myeloma.
First Author: Amman Bhasin
First Author: Cindy Revol
Poster
2022 ASCO Quality Care Symposium
Real-world variability in use of bone-modifying drugs for multiple myeloma by payer type.
First Author: SOPHIA Monica Monica Soni